Turner Syndrome
90
22
27
45
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
3 terminated out of 90 trials
93.8%
+7.2% vs benchmark
24%
22 trials in Phase 3/4
20%
9 of 45 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 45 completed trials
Clinical Trials (90)
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Natural History of Noncirrhotic Portal Hypertension
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases
Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome
Parental Project Amongst 93 Patients With Turner Syndrome
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Parent and Infant Inter(X)Action Intervention (PIXI)
Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome
Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome.
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome
Retrospective Analysis of the Neonatal Management of Patients with an Antenatal Diagnosis of Genital Development Variation At the Hospital of Lyon